Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Sauer

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Arthritis Care & Research|May 19, 2022
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine LearningBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Clinical Rheumatology|October 4, 2018
Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survivalBryant R England, Harlan Sayles, Kaleb Michaud, et al.
Journal of Biomedical Informatics|October 23, 2021
A new methodological framework for hazard detection models in health information technology systemsOlufemi A Omitaomu, Hilda B Klasky, Mohammed Olama, et al.
The American Journal of Cardiology|October 8, 2018
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina PectorisAdam P Bress, John A Dodson, Jordan B King, et al.
Future Oncology (London, England)|October 29, 2020
Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphomaHsu-Chih Chien, Deborah Morreall, Vikas Patil, et al.
The Journal of Rheumatology|August 17, 2014
Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.
Advances in Therapy|June 29, 2016
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid ArthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.
Respiratory Medicine|August 10, 2022
Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. VeteransJake G Natalini, Bryant R England, Joshua F Baker, et al.
Arthritis Care & Research|November 10, 2025
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)Madeline L O'Sullivan, Grant W Cannon, Brian C Sauer, et al.
Seminars in Arthritis and Rheumatism|May 7, 2024
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisJessica A Walsh, Shaobo Pei, Swetha Alexander, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Arthritis Care & Research|May 19, 2022
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine LearningBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Clinical Rheumatology|October 4, 2018
Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survivalBryant R England, Harlan Sayles, Kaleb Michaud, et al.
Journal of Biomedical Informatics|October 23, 2021
A new methodological framework for hazard detection models in health information technology systemsOlufemi A Omitaomu, Hilda B Klasky, Mohammed Olama, et al.
The American Journal of Cardiology|October 8, 2018
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina PectorisAdam P Bress, John A Dodson, Jordan B King, et al.
Future Oncology (London, England)|October 29, 2020
Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphomaHsu-Chih Chien, Deborah Morreall, Vikas Patil, et al.
The Journal of Rheumatology|August 17, 2014
Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.
Advances in Therapy|June 29, 2016
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid ArthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.
Respiratory Medicine|August 10, 2022
Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. VeteransJake G Natalini, Bryant R England, Joshua F Baker, et al.
Arthritis Care & Research|November 10, 2025
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)Madeline L O'Sullivan, Grant W Cannon, Brian C Sauer, et al.
Seminars in Arthritis and Rheumatism|May 7, 2024
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisJessica A Walsh, Shaobo Pei, Swetha Alexander, et al.
Pageof 12